ZA82740B - Novel sesquihydrate of naphthyridine derivative,and process for the preparation thereof - Google Patents

Novel sesquihydrate of naphthyridine derivative,and process for the preparation thereof

Info

Publication number
ZA82740B
ZA82740B ZA82740A ZA82740A ZA82740B ZA 82740 B ZA82740 B ZA 82740B ZA 82740 A ZA82740 A ZA 82740A ZA 82740 A ZA82740 A ZA 82740A ZA 82740 B ZA82740 B ZA 82740B
Authority
ZA
South Africa
Prior art keywords
sesquihydrate
novel
preparation
naphthyridine derivative
naphthyridine
Prior art date
Application number
ZA82740A
Other languages
English (en)
Inventor
Ichihashi Hitoshi
Tanaka Terukazu
Imasato Yu
Original Assignee
Dainippon Pharmaceutical Co
Bellon Labor Sa Roger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co, Bellon Labor Sa Roger filed Critical Dainippon Pharmaceutical Co
Publication of ZA82740B publication Critical patent/ZA82740B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77—Hydrazine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA82740A 1981-02-13 1982-02-05 Novel sesquihydrate of naphthyridine derivative,and process for the preparation thereof ZA82740B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56020749A JPS57134482A (en) 1981-02-13 1981-02-13 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation

Publications (1)

Publication Number Publication Date
ZA82740B true ZA82740B (en) 1982-12-29

Family

ID=12035831

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA82740A ZA82740B (en) 1981-02-13 1982-02-05 Novel sesquihydrate of naphthyridine derivative,and process for the preparation thereof

Country Status (19)

Country Link
US (1) US4442101A (xx)
EP (1) EP0058614B1 (xx)
JP (1) JPS57134482A (xx)
KR (1) KR870000322B1 (xx)
AU (1) AU547082B2 (xx)
CA (1) CA1216292A (xx)
CS (1) CS254958B2 (xx)
DD (1) DD202573A5 (xx)
DE (1) DE3266261D1 (xx)
DK (1) DK160046C (xx)
ES (1) ES8307793A1 (xx)
FI (1) FI71144C (xx)
HU (1) HU186473B (xx)
MX (1) MX158194A (xx)
NO (1) NO156721C (xx)
PH (1) PH18177A (xx)
PL (1) PL137259B1 (xx)
YU (1) YU43785B (xx)
ZA (1) ZA82740B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2758259A (en) * 1953-06-23 1956-08-07 Mallory & Co Inc P R Electrolytic capacitor device
US2856570A (en) * 1954-06-02 1958-10-14 Mallory & Co Inc P R Electrolytic capacitor
JPS57134482A (en) * 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation
DE3308908A1 (de) * 1983-03-12 1984-09-13 Bayer Ag, 5090 Leverkusen Bakterizide mittel
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
HUT40429A (en) * 1985-04-29 1986-12-28 Chinoin Gyogyszer Es Vegyeszet Process for production of salts of derivatives of kynolin carbonic acid
US5466696A (en) * 1992-09-10 1995-11-14 Warner Lambert Company Tacrine and cytochrome P450 oxidase inhibitors and methods of use
US5422350A (en) * 1992-09-10 1995-06-06 Warner-Lambert Company Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use
JP3449658B2 (ja) * 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法
GB9820405D0 (en) * 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US8629178B2 (en) * 2009-11-03 2014-01-14 Li Liu Sodium tanshinone IIA sulfonate hydrate and preparation method and use thereof
MX2015011651A (es) * 2013-03-08 2016-08-08 Melinta Therapeutics Inc Formas cristalinas de d-glucitol,1-desoxi-1-(metilamino)-,1-(6-ami no-3,5-difluoropiridin-2-il)-8-cloro-6-fluoro-1,4-dihidro-7-(3-hi droxiazetidin-1-il)-4-oxo-3-quinolincarboxilato.
KR102214067B1 (ko) 2014-02-27 2021-02-09 엘지전자 주식회사 산 질화물 형광체, 그 제조 방법 및 이를 이용한 발광 소자 패키지

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) * 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
US3590036A (en) * 1968-11-18 1971-06-29 George Y Lesher Naphthyridine-3-carboxylic acids,their derivatives and preparation thereof
DE2103805C3 (de) * 1970-01-28 1980-03-20 Sumitomo Chemical Co., Ltd., Osaka (Japan) Verfahren zur Herstellung von N-substituierten 6,7-Methylendioxy-4chinolonen
US4017622A (en) * 1972-12-18 1977-04-12 Dainippon Pharmaceutical Co., Ltd. Piperazine derivatives
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
JPS5845426B2 (ja) * 1978-09-29 1983-10-08 杏林製薬株式会社 置換キノリンカルボン酸誘導体
JPS57134482A (en) * 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation

Also Published As

Publication number Publication date
KR870000322B1 (ko) 1987-02-27
NO820430L (no) 1982-08-16
FI71144C (fi) 1986-11-24
YU43785B (en) 1989-12-31
AU547082B2 (en) 1985-10-03
EP0058614B1 (en) 1985-09-18
JPH0243753B2 (xx) 1990-10-01
DK63482A (da) 1982-08-14
YU26582A (en) 1986-04-30
MX158194A (es) 1989-01-16
FI71144B (fi) 1986-08-14
CS254958B2 (en) 1988-02-15
PH18177A (en) 1985-04-12
KR830009096A (ko) 1983-12-17
AU8017382A (en) 1982-08-19
US4442101A (en) 1984-04-10
DK160046C (da) 1991-06-10
DK160046B (da) 1991-01-21
PL235049A1 (xx) 1982-09-27
JPS57134482A (en) 1982-08-19
DE3266261D1 (en) 1985-10-24
CA1216292A (en) 1987-01-06
ES509538A0 (es) 1983-08-01
EP0058614A1 (en) 1982-08-25
CS99882A2 (en) 1987-07-16
ES8307793A1 (es) 1983-08-01
DD202573A5 (de) 1983-09-21
NO156721B (no) 1987-08-03
PL137259B1 (en) 1986-05-31
HU186473B (en) 1985-08-28
FI820466L (fi) 1982-08-14
NO156721C (no) 1987-11-11

Similar Documents

Publication Publication Date Title
DE3261029D1 (en) Isoquinolinesulfonyl derivatives and process for the preparation thereof
DE3270360D1 (en) Cephalosporin derivatives, and process for their preparation
PT75115B (en) Process for preparing novel imidazo <1,2-a> pyridines and pyra-zines
PT76596B (en) Process for preparing 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives
ZA82740B (en) Novel sesquihydrate of naphthyridine derivative,and process for the preparation thereof
PT75815A (en) Process for preparing morphinane derivatives and pharmaceutical compositions containing the same
DE3278474D1 (en) Process for the preparation of di-galactose derivatives
AR240739A1 (es) Procedimiento para preparar derivados de quinolinona
PT75784A (en) Process for the preparation of eburnamonine derivatives
DE3372758D1 (en) Process for preparing 2-carbamoyloxyalkyl-1,4-dihydropyridine derivatives and intermediates useful for the process
IL70659A (en) Process for the preparation of 2,3-dihalo pyridines
SG11288G (en) N-acytylneuraminic acid derivatives and process for the preparation thereof
EP0155710A3 (en) Process for the preparation of derivatives of polyethoxypropanesulfonates
PT74254B (en) Process for the preparation of pyridinyl-substituted-benzimidazole derivatives
ZA856431B (en) 1,6-naphthyridine derivatives,process for the preparation and the use thereof
DE3264284D1 (en) Bisimidazolines, process for their preparation and their use
ZA845708B (en) Novel 1,8-naphthyridine derivatives,and processes for preparation thereof
GB2103207B (en) Substituted pyrrolo]2,1-bquinazolines and pyrido]2,1-bquinazolines and process for their prepara
DE3172032D1 (en) 7-oxoprostacyclin derivatives and process for the preparation thereof
IL64687A (en) Process for the preparation of 3-picoline
PT77756A (en) Process for the preparation of pyridone derivatives
IL67581A (en) Aminopropylaminobleomycin derivatives and process for preparation thereof
IL65539A0 (en) New 13-thia-prostacycline derivatives and process for the preparation thereof
DE3260445D1 (en) Process for the preparation of 17-alpha-ethynyl-17-beta-trifluoroacetoxy-gon-4-en-3-one derivatives
DE3262838D1 (en) Process for the preparation of pyridines